diltiazem has been researched along with tacrolimus in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (21.95) | 18.2507 |
2000's | 15 (36.59) | 29.6817 |
2010's | 13 (31.71) | 24.3611 |
2020's | 4 (9.76) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bauer, S; Brockmöller, J; Kewitz, H; Roots, I | 1 |
Endo, T; Koshiba, K; Kumano, K | 1 |
Endo, T; Kumano, K; Kuwao, S; Wang, G | 1 |
Alessiani, M; Iacona, I; Molinaro, M; Regazzi, MB; Spada, M; Vaccarisi, S; Villani, P | 1 |
Baltes, A; Becker, G; Hamar, P; Heemann, U; Philipp, T; Witzke, O | 1 |
Demetris, AJ; Gritsch, A; Jordan, M; Katari, SR; Magnone, M; McCauley, J; Randhawa, PS; Scantlebury, V; Shapiro, R; Starzl, T; Vivas, C | 1 |
Finney, NS | 1 |
Ito, K; Suzuki, T; Tada, H; Yanagiwara, S | 1 |
Hebert, MF; Lam, AY | 1 |
Chen, JC; Ma, P | 1 |
Jones, TE; Morris, RG | 1 |
Dietl, KH | 1 |
Bhaloo, S; Prasad, GV | 1 |
Bayle, F; Bessard, G; Contamin, C; Hardy, G; Serre-Debeauvais, F; Stanke-Labesque, F; Zaoui, P | 1 |
Kothari, J; Nash, M; Ramesh Prasad, GV; Zaltzman, J | 1 |
Balasubramaniam, R; Chawla, S; Grace, AA; Huang, CL | 1 |
Akhlaghi, F; Gleeson, M; McCaughan, G; McLachlan, AJ; Nelson, A; Zahir, H | 1 |
Chen, LQ; Chen, LZ; Chen, YH; Hu, JB; Li, WL; Liang, JJ; Liang, YX; Qiu, J; Xie, KJ; Zhang, J; Zheng, KL; Zhong, WD | 1 |
Fu, Q; Huang, M; Li, JL; Liu, LS; Wang, CX; Wang, XD; Zhou, SF | 1 |
Chen, LQ; Chen, LZ; Chen, YH; Hu, JB; Liang, JJ; Liang, YX; Lu, YM; Qiu, J; Wang, B; Xie, KJ; Zhang, J; Zheng, KL; Zhong, WD | 1 |
Chen, SY; Chen, X; Fu, Q; Huang, M; Li, JL; Liu, LS; Teng, LC; Wang, CX; Wang, XD | 1 |
Arase, S; Fukumoto, D; Hida, Y; Ishigami, T; Kubo, Y | 1 |
Gitman, M; Hazzan, A; Jhaveri, KD; Patni, H | 1 |
Houjo, T; Ishigai, M; Kato, M; Ogawa, K | 1 |
Chan, TM; Kwan, LP; Ma, MK; Mok, MM; Tang, CS; Yap, DY | 1 |
Ding, JJ; Guan, XF; Li, DY; Ma, RR; Wang, JL; Yin, WJ; Zhou, LY; Zuo, XC | 1 |
Chen, F; Ding, XS; Guo, HL; Hu, YH; Jing, X; Sun, F; Sun, JY; Xu, J; Xu, ZJ | 1 |
Chen, L; Chen, Y; Lei, W; Li, M; Liang, J; Lin, Y; Lu, Y; Yang, J; Zhang, J; Zhang, Z | 1 |
Ko, CJ; Siegel, JD | 1 |
Hiremath, J; Lodha, AR; Pillai, A; Sheth, K | 1 |
Bacon, S; Croker, R; Curtis, HJ; Goldacre, B; MacKenna, B; Walker, AJ | 1 |
Kunlamas, Y; Susomboon, T; Vadcharavivad, S; Vongwiwatana, A | 1 |
3 review(s) available for diltiazem and tacrolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Enantioselective epoxide hydrolysis: catalysis involving microbes, mammals and metals.
Topics: Antibodies, Catalytic; Antihypertensive Agents; Antineoplastic Agents; Catalysis; Diltiazem; Epothilones; Epoxy Compounds; Hydrolysis; Immunosuppressive Agents; Tacrolimus; Thiazoles | 1998 |
Diltiazem-associated photodistributed hyperpigmentation: report of two Japanese cases and published work review.
Topics: Aged, 80 and over; Asian People; Calcium Channel Blockers; Diltiazem; Drug Eruptions; Female; Humans; Hyperpigmentation; Japan; Photosensitivity Disorders; Tacrolimus; Treatment Outcome | 2010 |
6 trial(s) available for diltiazem and tacrolimus
Article | Year |
---|---|
Oral dosing of tacrolimus and cyclosporine microemulsion--results from a large multicenter study in renal transplantation.
Topics: Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Emulsions; Europe; Female; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Survival Analysis; Tacrolimus | 2002 |
Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Algorithms; Diltiazem; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Prednisolone; Retrospective Studies; Tacrolimus | 2005 |
Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective.
Topics: Adolescent; Adult; Algorithms; Calcium Channel Blockers; Chi-Square Distribution; China; Cytochrome P-450 CYP3A; Diltiazem; Drug Dosage Calculations; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Male; Middle Aged; Pharmacogenetics; Phenotype; Prospective Studies; Retrospective Studies; Tacrolimus; Young Adult | 2011 |
Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
Topics: Adult; Antihypertensive Agents; Chi-Square Distribution; China; Delayed-Action Preparations; Diltiazem; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Tacrolimus; Treatment Outcome | 2013 |
Population Pharmacokinetic Modeling of Diltiazem in Chinese Renal Transplant Recipients.
Topics: Adolescent; Adult; Antihypertensive Agents; Asian People; ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP3A; Diltiazem; Female; Genotype; Humans; Kidney Transplantation; Male; Middle Aged; Models, Biological; Polymorphism, Restriction Fragment Length; Tacrolimus; Young Adult | 2018 |
The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial.
Topics: Cytochrome P-450 CYP3A; Diltiazem; Genotype; Immunosuppressive Agents; Kidney Transplantation; Tacrolimus | 2022 |
32 other study(ies) available for diltiazem and tacrolimus
Article | Year |
---|---|
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of the new immunosuppressive drug FK506 on the formation of secondary metabolites of cyclosporin A.
Topics: Biotransformation; Cyclosporine; Diltiazem; Erythromycin; Humans; Immunosuppressive Agents; In Vitro Techniques; Microsomes, Liver; Tacrolimus | 1992 |
[Functional and morphological changes in rat kidney induced by FK506 and its reversal by various vasodilators].
Topics: Animals; Calcium; Captopril; Diltiazem; Hemodynamics; Kidney; Male; Necrosis; Prazosin; Rats; Rats, Inbred Strains; Tacrolimus | 1992 |
FK 506-induced nephrotoxicity in rats.
Topics: Animals; Anti-Bacterial Agents; Blood Pressure; Captopril; Diltiazem; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Male; Organ Size; Prazosin; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Tacrolimus; Vascular Resistance | 1991 |
Interaction between FK 506 and diltiazem in an animal model.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Drug Interactions; Immunosuppressive Agents; Infusions, Intravenous; Swine; Tacrolimus | 1996 |
Diltiazem minimizes tubular damage due to FK506-mediated nephrotoxicity following ischemia and reperfusion in rats.
Topics: Acetylglucosaminidase; Animals; Creatinine; Diltiazem; Ischemia; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Reperfusion; Tacrolimus | 1996 |
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Biopsy, Needle; Clarithromycin; Creatinine; Diltiazem; Drug Interactions; Female; Humans; Hyperglycemia; Hyperkalemia; Hypertension; Immunosuppressive Agents; Infusions, Intravenous; Itraconazole; Kidney; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Time Factors; Transplantation, Homologous; Tremor; Ultrasonography; Vasodilator Agents | 1997 |
Role of diltiazem on tacrolimus pharmacokinetics in tacrolimus-induced nephrotoxic rats.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Immunosuppressive Agents; Kidney; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Kidney Medulla; Male; Rats; Rats, Sprague-Dawley; Tacrolimus; Tissue Distribution | 1999 |
Diltiazem increases tacrolimus concentrations.
Topics: Aged; Calcium Channel Blockers; Diltiazem; Drug Interactions; Graft Rejection; Humans; Immunosuppressive Agents; Infusions, Intravenous; Liver Transplantation; Male; Psychoses, Substance-Induced; Tacrolimus | 1999 |
Mechanism of FK506-induced renal hypoperfusion and its reversion in rats.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Drug Interactions; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perfusion; Rats; Rats, Sprague-Dawley; Tacrolimus; Urination | 2001 |
Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients.
Topics: Area Under Curve; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Tacrolimus | 2002 |
Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report.
Topics: Adult; Clarithromycin; Creatinine; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Rifampin; Tacrolimus | 2003 |
Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report.
Topics: Adult; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diagnosis, Differential; Diltiazem; Drug Interactions; HIV Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Protease Inhibitors; Tacrolimus | 2004 |
Diltiazem use in tacrolimus-treated renal transplant recipients.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Diltiazem; Female; Health Care Costs; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus | 2004 |
Caffeine-induced arrhythmias in murine hearts parallel changes in cellular Ca(2+) homeostasis.
Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Cytosol; Diltiazem; Electric Stimulation; Homeostasis; Immunosuppressive Agents; In Vitro Techniques; Mice; Mice, Inbred Strains; Myocytes, Cardiac; Nifedipine; Perfusion; Phosphodiesterase Inhibitors; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular; Tacrolimus | 2005 |
[Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
Topics: Animals; Creatine; Cyclosporine; Diltiazem; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; Kidney Transplantation; Male; Postoperative Period; Random Allocation; Rats; Rats, Sprague-Dawley; Tacrolimus | 2007 |
Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study.
Topics: Chromatography, High Pressure Liquid; Diltiazem; Drug Interactions; Humans; Immunosuppressive Agents; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tacrolimus; Tandem Mass Spectrometry | 2008 |
[Nephrotoxicity of tacrolimus and preventive effect of diltiazem: experiment with rats].
Topics: Animals; Diltiazem; Kidney; Kidney Transplantation; Male; Rats; Rats, Sprague-Dawley; Tacrolimus | 2009 |
Ranolazine, tacrolimus, and diltiazem might be a hazardous combination in a transplant patient.
Topics: Acetanilides; Acute Kidney Injury; Calcium Channel Blockers; Diltiazem; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Piperazines; Postoperative Complications; Ranolazine; Tacrolimus | 2012 |
A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data.
Topics: Alprazolam; Animals; Cytochrome P-450 CYP3A; Diltiazem; Humans; Liver; Macaca fascicularis; Midazolam; Tacrolimus | 2013 |
Diltiazem used as a tacrolimus-sparing agent for treatment of pediatric patients with refractory nephrotic syndrome: a case report and retrospective analysis.
Topics: Child; Child, Preschool; Cytochrome P-450 CYP3A; Diltiazem; Drug Interactions; Drug Resistance; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Retrospective Studies; Tacrolimus; Treatment Outcome | 2019 |
Diltiazem aggravates testicular function impairment induced by cyclosporine A or tacrolimus in unilateral nephrectomised rats.
Topics: Animals; Calcineurin Inhibitors; Calcium Channel Blockers; Cyclosporine; Diltiazem; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gonadal Steroid Hormones; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Microscopy, Electron, Transmission; Nephrectomy; Rats; Rats, Sprague-Dawley; Semen Analysis; Sperm Motility; Tacrolimus; Testis | 2019 |
Diltiazem-associated Photodistributed Hyperpigmentation.
Topics: Aged; Biopsy; Calcium Channel Blockers; Dermatologic Agents; Diltiazem; Female; Humans; Hyperpigmentation; Hypertension; Ointments; Photosensitivity Disorders; Skin; Tacrolimus; Treatment Outcome; Withholding Treatment | 2020 |
A retrospective cohort study exploring diltiazem as a pharmaco-enhancer for tacrolimus, in a post-heart transplant setting.
Topics: Diltiazem; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Retrospective Studies; Tacrolimus | 2020 |
Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care.
Topics: Cohort Studies; Cyclosporine; Diltiazem; Electronic Health Records; England; Female; Humans; Inappropriate Prescribing; Male; Primary Health Care; Retrospective Studies; Tacrolimus | 2020 |